MedTrace Logo

A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma

NCT00201396 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 480

Last updated 2015-02-25

No results posted yet for this study

Summary

Investigate the effect of induction MEPFL chemotherapy followed by concurrent chemoradiotherapy (CCRT) on the disease control and survival in treatment of patients with advanced NPC.

Conditions

  • Nasopharyngeal Carcinoma

Interventions

RADIATION

CCRT

Radiation with weekly Cisplatin

DRUG

Mitomycin C,Epirubicin,Cisplatin,5-Fluorouracil,Leucovorin

Induction C/T + CCRT

Sponsors & Collaborators

  • National Taiwan University Hospital

    collaborator OTHER

  • Tri-Service General Hospital

    collaborator OTHER

  • Chang Gung Memorial Hospital

    collaborator OTHER

  • China Medical University Hospital

    collaborator OTHER

  • Chung Shan Medical University

    collaborator OTHER

  • Changhua Christian Hospital

    collaborator OTHER

  • Chi Mei Medical Hospital

    collaborator OTHER

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    collaborator OTHER

  • Kaohsiung Veterans General Hospital.

    collaborator OTHER

  • Taipei Veterans General Hospital, Taiwan

    collaborator OTHER_GOV

  • National Health Research Institutes, Taiwan

    lead OTHER

Principal Investigators

  • Ruey-Long Hong, MD, PhD · Taiwan cooperative oncology group

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-08-31
Primary Completion
2009-08-31
Completion
2011-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00201396 on ClinicalTrials.gov